High Throughput Measurement of Ca++ Dynamics in Human Stem Cell-Derived Cardiomyocytes by Kinetic Image Cytometery: A
Hua Rong Lu1, Ross Whittaker2, Jeffrey H Price2
1*Global Safety Pharmacology, Preclinical Development & Safety, Discovery Sciences, Janssen Pharmaceutical NV, B2340 Beerse, Belgium; hlu@its.jnj.com.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|September 12, 2015
Summary
Human induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs) and the Kinetic Image Cytometer (KIC) system effectively predict drug-induced cardiac risks. This approach aids early identification of compounds with arrhythmogenic liabilities in drug discovery.
Area of Science:
- Cardiovascular pharmacology
- Stem cell biology
- Drug safety assessment
Background:
- Human induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs) offer a promising in vitro model for cardiac safety evaluation.
- Early identification of cardiotoxic drug candidates is crucial in the drug discovery process to mitigate risks.
Purpose of the Study:
- To evaluate the Kinetic Image Cytometer (KIC) system's capability in predicting adverse compound effects using hiPS-CMs.
- To assess the KIC system's utility in detecting drug-induced changes in cardiomyocyte function and predicting arrhythmogenic liabilities.
Main Methods:
- Utilized hiPS-CMs and a library of 53 compounds, including known cardioactive agents and negative controls.
- Employed the KIC system for high-throughput analysis of intracellular calcium transients in hiPS-CMs.
- Examined drug-induced alterations in calcium transient dynamics, including duration and beat rate, as indicators of compound effects.
Main Results:
- The KIC system accurately detected drug-induced changes in Ca(2+) transient dynamics in hiPS-CMs.
- The study demonstrated the KIC's ability to assess compound effects across multiple ion channel types (MITs) and calcium handling pathways.
- Results from this blinded study suggest a strong correlation between observed calcium transient changes and potential arrhythmogenic liabilities.
Conclusions:
- The KIC system, in conjunction with hiPS-CMs, shows significant potential for predicting drug-induced arrhythmogenic liabilities.
- This approach can serve as an effective phenotypic screen for early de-risking in the drug discovery pipeline.
- Utilizing hiPS-CMs and KIC facilitates a more accurate and timely assessment of cardiac safety profiles for novel compounds.


